Turkey los­es bid at WTO de­mand­ing all for­eign phar­ma com­pa­nies make drugs lo­cal­ly

The EU has pre­vailed in a trade dis­pute with Turkey over whether phar­ma com­pa­nies should be re­quired to make their drugs in Turkey, ac­cord­ing to a World Trade Or­ga­ni­za­tion state­ment on Mon­day.

Back in 2017, the Turk­ish gov­ern­ment ini­ti­at­ed a pro­gram that called for delist­ing im­port­ed drugs from its re­im­burse­ment list if they are not pro­duced lo­cal­ly, and it pro­vides pref­er­en­tial re­im­burse­ment for do­mes­tic prod­ucts, ac­cord­ing to a PhRMA re­port from late last year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER